Lenvatinib-induced psoriasiform eruption and palmoplantar erythema in a patient with hepatocellular carcinoma

Rachel Sally; Nkemjika Ugonabo; Andy Nguyen; Randie H Kim; Kristen Lo Sicco

doi:10.1016/j.jdcr.2021.07.001

Lenvatinib-induced psoriasiform eruption and palmoplantar erythema in a patient with hepatocellular carcinoma

JAAD Case Rep. 2021 Jul 13:15:1-3. doi: 10.1016/j.jdcr.2021.07.001. eCollection 2021 Sep.

Authors

Rachel Sally¹, Nkemjika Ugonabo¹, Andy Nguyen¹, Randie H Kim¹, Kristen Lo Sicco¹

Affiliation

¹ Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York.

No abstract available

Keywords: HCC, hepatocellular carcinoma; MKI, multikinase inhibitor; VEGF, vascular endothelial growth factor; VEGFR, vascular endothelial growth factor receptor; drug eruption; hepatocellular carcinoma; lenvatinib; psoriasiform drug eruption; psoriasis; tyrosine kinase inhibitors.

Publication types

Case Reports